JPRN-UMIN000006759招募中2 期
Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung cancer - Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung cancer
niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery0 个研究点目标入组 30 人开始时间: 2011年11月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Uncontrolled infection or Serious medical complications 2)Uncontrollable diabetes mellitus 3)Uncontrollable hypertension 4)Therapeutic anticoagulopathy (except Aspirin within 325mg/day) 5)Current or previous history of hemoptysis 6)Evidence of bleeding diathesis or hemoptysis 7)With great vessel invasion 8)Cavity in tumor 9)Uncontrollable gastrointestinal ulceration 10)Current or previous(within the last 1 year) history of GI perforration 11)History of severe heart disease 12)Interstitial pneumonia or pulmonary fibrosis detectableon chest X-ray 13)Multiple primary cancer 14)With a history of drug sensitivity 15)Patients who do not want to take vitamin preparation 16)Serious psychiatric illness or psychological symptom 17)Women who are pregnant, lactating or with childbearing potential 18)Ineligible based on decision of an investigator.
研究者
相似试验
招募中
2 期
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancerresectable pancreatic cancerJPRN-UMIN000005912Tokai university, school of medicine50
已完成
2 期
Phase II study of neoadjuvant chemotherapy with CPT-11 and S-1 for locally advanced colorectal cancer with lymph node metastases.locally advanced colorectal cancer with lymph node metastasesJPRN-UMIN000001698iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
已完成
不适用
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
已完成
不适用
Feasibility study of adjuvant chemotherapy with carboplatin and nab-paclitaxel for resected NSCLCresected NSCLC(stage II - IIIB)JPRN-UMIN000011910Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine21
招募中
2 期
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerC535836pancreatic cancerJPRN-jRCT1041230068Ebata Tomoki50